{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:25:59Z","timestamp":1777908359435,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007254","name":"Creighton University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R15 AI164443"],"award-info":[{"award-number":["R15 AI164443"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P20 GM139762\\u201301"],"award-info":[{"award-number":["P20 GM139762\\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Results in Chemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.rechem.2025.102307","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T01:37:48Z","timestamp":1745717868000},"page":"102307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pre-formulation development of highly potent nontuberculous mycobacterial agents"],"prefix":"10.1016","volume":"15","author":[{"given":"Satish G.","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jeffrey","family":"North","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alekha K.","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rechem.2025.102307_bb0055","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/CMR.15.4.716-746.2002","article-title":"Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria","volume":"15","author":"Brown-Elliott","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.rechem.2025.102307_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/809014","article-title":"General overview on nontuberculous mycobacteria, biofilms, and human infection","volume":"2015","author":"Faria","year":"2015","journal-title":"J. Pathog."},{"key":"10.1016\/j.rechem.2025.102307_bb0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3201\/eid1403.061143","article-title":"Epidemiology of nontuberculous mycobacteria in patients without HIV infection","volume":"14","author":"Bodle","year":"2008","journal-title":"New York City. Emerg. Infect. Dis."},{"key":"10.1016\/j.rechem.2025.102307_bb0115","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.bmc.2017.05.015","article-title":"Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity","volume":"25","author":"Franz","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.rechem.2025.102307_bb0260","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3201\/eid1610.091201","article-title":"Changing epidemiology of pulmonary nontuberculous mycobacteria infections","volume":"16","author":"Thomson","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.rechem.2025.102307_bb0230","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.3390\/ijms21176202","article-title":"MmpL3 inhibition: a new approach to treat nontuberculous mycobacterial infections","volume":"21","author":"Sethiya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rechem.2025.102307_bb0175","doi-asserted-by":"crossref","first-page":"e02245","DOI":"10.1128\/AAC.02245-18","article-title":"Indole-2-carboxamides are active against mycobacterium abscessus in a mouse model of acute infection","volume":"63","author":"Pandya","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rechem.2025.102307_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3907","article-title":"Indoleamides are active against drug-resistant mycobacterium tuberculosis","volume":"4","author":"Lun","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.rechem.2025.102307_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007355","article-title":"Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis","volume":"5","author":"Rao","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.rechem.2025.102307_bb0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/acs.jmedchem.2c00352","article-title":"Structural determinants of Indole-2-carboxamides: Identification of lead acetamides with pan antimycobacterial activity","volume":"66","author":"Bhattarai","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.rechem.2025.102307_bb0140","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1021\/jm4012774","article-title":"Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents","volume":"56","author":"Kondreddi","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.rechem.2025.102307_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2006.10.010","article-title":"Pharmaceutical impurities: regulatory perspective for abbreviated new drug applications","volume":"59","author":"Basak","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.rechem.2025.102307_bb0035","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1517\/17425247.2013.783563","article-title":"Impact of preformulation on drug development","volume":"10","author":"Bharate","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.rechem.2025.102307_bb0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.rechem.2025.102307_bb0170","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1021\/jm4003878","article-title":"Preliminary structure\u2013activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant mycobacterium tuberculosis strains","volume":"56","author":"Onajole","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.rechem.2025.102307_bb0090","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0731-7085(02)00167-X","article-title":"A simple LC method with UV detection for the analysis of creatine and creatinine and its application to several creatine formulations","volume":"29","author":"Dash","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.rechem.2025.102307_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2229-5186.79345","article-title":"Methods for the determination of limit of detection and limit of quantitation of the analytical methods","volume":"2","author":"Shrivastava","year":"2011","journal-title":"Chron Young Sci"},{"key":"10.1016\/j.rechem.2025.102307_bb0080","series-title":"Silica-Encapsulated Germania Colloids as 3D-Printable Glass Precursors","author":"Chinn","year":"2022"},{"key":"10.1016\/j.rechem.2025.102307_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105514","article-title":"Patterns of drug release as a function of drug loading from amorphous solid dispersions: a comparison of five different polymers","volume":"155","author":"Saboo","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.rechem.2025.102307_bb0225","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/acs.jced.9b01129","article-title":"Experimental determination of octanol\u2013water partition coefficients of selected natural toxins","volume":"65","author":"Sch\u00f6nsee","year":"2020","journal-title":"J. Chem. Eng. Data"},{"key":"10.1016\/j.rechem.2025.102307_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10629369508050157","article-title":"Validation of pH-metric technique for measurement of pKa and log pow of ionizable herbicides","volume":"3","author":"Comer","year":"1995","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.rechem.2025.102307_bb0205","doi-asserted-by":"crossref","first-page":"ACI-S12304","DOI":"10.4137\/ACI.S12304","article-title":"Development of methods for the determination of pKa values","volume":"8","author":"Reijenga","year":"2013","journal-title":"Anal. Chem. Insights"},{"key":"10.1016\/j.rechem.2025.102307_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","article-title":"Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound","volume":"46","author":"Baka","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.rechem.2025.102307_bb0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10601330701273669","article-title":"Classification of drug permeability with a Caco-2 cell monolayer assay","volume":"24","author":"Volpe","year":"2007","journal-title":"Clin. Res. Regul. Aff."},{"key":"10.1016\/j.rechem.2025.102307_bb0065","first-page":"2249","article-title":"Stability indicating analytical method development and validation for estimation of orlistat in bulk and its dosage form by HPTLC technique and finding degradants by LC-MS","volume":"3","author":"Chaudhry","year":"2018","journal-title":"Am J Pharm Res"},{"key":"10.1016\/j.rechem.2025.102307_bb0075","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jpba.2010.12.020","article-title":"An overview of recent studies on the analysis of pharmaceutical polymorphs","volume":"55","author":"Chieng","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.rechem.2025.102307_bb0160","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/092986709787549299","article-title":"Polymorphism and crystallization of active pharmaceutical ingredients (APIs)","volume":"16","author":"Lu","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.rechem.2025.102307_bb0070","first-page":"1","article-title":"Powder XRD technique and its applications in science and technology","volume":"5","author":"Chauhan","year":"2014","journal-title":"J Anal Bioanal Tech"},{"key":"10.1016\/j.rechem.2025.102307_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42649-020-00032-9","article-title":"Hot stage microscopy and its applications in pharmaceutical characterization","volume":"50","author":"Kumar","year":"2020","journal-title":"Appl. Microsc."},{"key":"10.1016\/j.rechem.2025.102307_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF01197379","article-title":"On the polymorphism of pharmaceuticals and other molecular crystals","volume":"72","author":"Burger","year":"1979","journal-title":"I. Microchim. Acta"},{"key":"10.1016\/j.rechem.2025.102307_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/3527607889.ch11","article-title":"Approaches to polymorphism screening","author":"Hilfiker","year":"2006","journal-title":"Polymorph. Pharm. Ind."},{"key":"10.1016\/j.rechem.2025.102307_bb0265","first-page":"1","article-title":"Jones, chapter 1: Preformulation studies in pharmaceutical formulation. Drug discovery series no. 64, the science and Technology of Dosage Forms","volume":"2018","author":"Trevor","year":"2018","journal-title":"The Royal Society of Chemistry"},{"key":"10.1016\/j.rechem.2025.102307_bb0185","series-title":"British Pharmacopoeia. Medicinal and Pharmaceutical Substances. \u2013 London: The Stationery Office","author":"Pharmacopoeia B","year":"2010"},{"key":"10.1016\/j.rechem.2025.102307_bb0255","series-title":"The United States Pharmacopeial Convention, NF42, 42nd ed. Rockville, MD","author":"The United States Pharmacopeia","year":"2020"},{"key":"10.1016\/j.rechem.2025.102307_bb0095","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1023\/A:1015858503031","article-title":"Solid-state properties of tobramycin","volume":"8","author":"Dash","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.rechem.2025.102307_bb0270","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s11095-009-9921-3","article-title":"Powder dissolution method for estimating rotating disk intrinsic dissolution rates of low solubility drugs","volume":"26","author":"Tsinman","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.rechem.2025.102307_bb0240","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1021\/mp400713v","article-title":"Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition","volume":"11","author":"Smith","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.rechem.2025.102307_bb0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.04.012","article-title":"Buccal bioadhesive drug delivery\u2014a promising option for orally less efficient drugs","volume":"114","author":"Sudhakar","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.rechem.2025.102307_bb0275","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chroma.2003.10.084","article-title":"Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution","volume":"1037","author":"Valk\u00f3","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.rechem.2025.102307_bb0195","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1590\/S0100-40422012000200028","article-title":"Studies on the development of spectrophotometric method for the determination of haloperidol in pharmaceutical preparations","volume":"35","author":"Rahman","year":"2012","journal-title":"Qu\u00edm. Nova"},{"key":"10.1016\/j.rechem.2025.102307_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpba.2009.12.003","article-title":"In vitro food\u2013drug interaction study: which milk component has a decreasing effect on the bioavailability of ciprofloxacin?","volume":"52","author":"P\u00e1pai","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.rechem.2025.102307_bb0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/ph14060545","article-title":"Meta-assessment of metformin absorption and disposition pharmacokinetics in nine species","volume":"14","author":"Jeong","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.rechem.2025.102307_bb0190","series-title":"A Novel Mechanism for Intestinal Absorption of the Type II Diabetes Drug Metformin: Role of Cation-Selective Apical Transporters in Paracellular Absorption","author":"Proctor","year":"2010"},{"key":"10.1016\/j.rechem.2025.102307_bb0215","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1023\/B:PHAM.0000026423.48583.e2","article-title":"Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans","volume":"21","author":"Saitoh","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.rechem.2025.102307_bb0220","series-title":"Drug solubility: importance and enhancement techniques","first-page":"2012","author":"Savjani","year":"2012"}],"container-title":["Results in Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211715625002905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211715625002905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:03:13Z","timestamp":1777644193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211715625002905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":45,"alternative-id":["S2211715625002905"],"URL":"https:\/\/doi.org\/10.1016\/j.rechem.2025.102307","relation":{},"ISSN":["2211-7156"],"issn-type":[{"value":"2211-7156","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-formulation development of highly potent nontuberculous mycobacterial agents","name":"articletitle","label":"Article Title"},{"value":"Results in Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rechem.2025.102307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102307"}}